Anti-obesity action of gingerol: Effect on lipid profile, insulin, leptin, amylase and lipase in male obese rats induced by a high-fat diet

Journal of the Science of Food and Agriculture

Volumn 94, Issue 14, 2014, Pages 2972-2977

  Saravanan, Ganapathy ^a   Ponmurugan, Ponnusamy ^b   Deepa, Machampalayam Arumugam ^c   Senthilkumar, Balasubramanian ^d,e  

^a K S RANGASAMY COLLEGE OF ARTS AND SCIENCE AUTONOMOUS   (India)

^b K S RANGASAMY COLLEGE OF TECHNOLOGY   (India)

^c KRISTU JAYANTI COLLEGE   (India)

^d C ABDUL HAKEEM COLLEGE   (India)

^e Department of Zoology Thriruvalluvar University   (India)

Author keywords

Anti obesity effect; Gingerol; High fat diet

Indexed keywords

RATTUS; ZINGIBER OFFICINALE;

AMYLASE; ANTIOBESITY AGENT; CATECHOL DERIVATIVE; FAT INTAKE; FATTY ALCOHOL; GINGEROL; GLUCOSE BLOOD LEVEL; INSULIN; LEPTIN; LIPID; TRIACYLGLYCEROL LIPASE;

ADVERSE EFFECTS; ANIMAL; BLOOD; CHEMICAL STRUCTURE; CHEMICALLY INDUCED; CHEMISTRY; DRUG EFFECTS; FAT INTAKE; GLUCOSE BLOOD LEVEL; MALE; METABOLISM; OBESITY; RAT; WEIGHT REDUCTION;

AMYLASES; ANIMALS; ANTI-OBESITY AGENTS; BLOOD GLUCOSE; CATECHOLS; DIETARY FATS; FATTY ALCOHOLS; INSULIN; LEPTIN; LIPASE; LIPIDS; MALE; MOLECULAR STRUCTURE; OBESITY; RATS; WEIGHT LOSS;

EID: 84917744436     PISSN: 00225142     EISSN: 10970010     Source Type: Journal    
DOI: 10.1002/jsfa.6642     Document Type: Article

References (34)

1. Canbakan B, Tahan V, Balci H, Hatemi I, Erer B, Ozbay G, et al, Leptin in nonalcoholic fatty liver disease. Ann Hepatol 7:249-254 (2008).
2. Bray GA and Bellanger T, Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine 29:109-117 (2006).
3. Pittler MH and Ernst E, Dietary supplements for body-weight reduction: A systematic review. Am J Clin Nutr 79:529-536 (2004).
4. Kishino E, Ito T, Fujita K and Kiuchi Y, Amixture of the Salacia reticulata (Kotala himbutu) aqueous extract and cyclodextrin reduces the accumulation of visceral fat mass in mice and rats with high-fat diet-induced obesity. J Nutr 136:433-439(2006).
5. Taspell LC, Hampell I and Cobiac CS, Health benefits of herbs and spices. Med J Austria 185:4-24(2006).
6. John H, Beattie F and Margaret JG, Ginger phytochemicals mitigate the obesogenic effects of a high-fat diet in mice: A proteomic and biomarker network analysis. Mol Nutr Food Res 55:S203-S213 (2011).
7. Available: http://en.wikipedia.org/wiki/Gingerol. [29 October 2013].
8. Shih MF and Cherny JY, Preventing dyslipidemia by Chlorella pyrenoidosa in rats and hamsters after chronic high fat diet treatment. Life Sci 76:3001-3013 (2005).
9. Mattews DR, Hosker JP, Rudenski AS and Naylor BA, Homeostasis model assessment: Insulin resistance beta cell functions fromfasting plasma insulin concentrations in man. Diabetologia 28:412-419 (1985).
10. Kusunoki M, Hara T, Tsutsumi K, Nakamura T, Miyata Y and Sakakibara F, The lipoprotein lipase activator, NO-1886, suppresses fat accumulation and insulin resistance in rats fed a high fat diet. Diabetologia 43:875-880 (2000).
11. Bull NL, Studies of dietary habits, food consumption and nutrient intake of adolescents and young adults. World Rev Nutr Diet 57:24-74 (1988).
12. Min Liu I, Thing-Fong T, Shorong-Shii L and Chia Ju C, Regulation of obesity and lipid disorders by extracts from Angelica acutiloba root in high-fat diet-induced obese rats. Phytother Res 26:223-230 (2012).
13. Jungmin OH, Jung S, Yun-jeong L and Kye won P, Antioxidant and antiobesity activities of seed extract from Campbell early grape as a functional ingredient. J Food Prod Preserve 37:291-298 (2013).
14. Srinivasan K, Patole PS, Kaul CL and Ramarao P, Reversal of glucose intolerance by pioglitazone in high-fat diet fed rats. Exp Clin Pharmacol 26:327-333 (2004).
15. Björntorp P, Number and size of adipose tissue fat cells in relation to metabolism in human obesity. Metabolism 20:703-713(1971).
16. Iwasaki Y, Morita I and Iwasawa K, The non-pungent component gingerol increases adrenalin secretion via activation of TRPV1. Nutr Neurosci 96:169-178 (2006).
17. Randle PJ, Garland PB, Hales CN and Newsholme EA, The glucose-fatty acid cycle. Its role in insulin sensitivity andmetabolic disturbances in diabetes mellitus. Lancet 1:785-789 (1963).
18. Akhani SP, Viswakarma SL and Goyal RK, Antidiabetic effect of Zingiber officinale in STZ induced type 1 diabetic rats. J Pharm Pharmacol 56:101-104 (2004).
19. Park Y, Storkson JM, Liu W, Albright J, Cook ME and Pariza MW, Structure-activity relationship of conjugated linoleic acid and its cognates in inhibiting heparin-releasable lipoprotein lipase and glycerol release from fully differentiated 3T3-L1 adipocytes. J Nutr Biochem 15:561-569 (2004).
20. Saravanan G and Ponmurugan P, Ameliorative potential of S-allylcysteine: Effect on lipid profile and changes in tissue fatty acid composition in experimental diabetes. Exp Toxicol Pathol 64:639-644 (2012).
21. Fungwe TV, Cagen LM and Cook GA, Dietary cholesterol stimulated hepatic biosynthesis of triglyceride and reduces oxidation of fatty acids in the rat. J Lipid Res 34:933-941 (1993).
22. Shi Y and Burn P, Lipid metabolic enzymes: emerging drug targets for the treatment of obesity. Nat Rev Drug Discoeryv 3:695-710 (2004).
23. Cohn RM and Roth KS, Lipid and Lipoprotein Metabolism. Biochemistry and Disease. Williams and Wilkins Publishers, Baltimore (1996).
24. Yongqi G, Guanzhong W, Xin S, Hongxia Y and Juan Z, Antiobesity action of a daidzein derivative on male obese mice induced by a high-fat diet. Nutr Res 29:656-663 (2009).
25. Bray G and Ryan D, Drug treatment of the overweight patient. Gastroenterology 132:2239-2252 (2007).
26. Van Gaal LF, Mertens IL and De Block CE, Mechanisms linking obesity with cardiovascular disease. Nature 444:875-880 (2006).
27. Pieper-Bigelow C, Strocchi A and Levitt MD, Where does serum amylase come from and where does it go? Gastroenterol Clin N Am 19:793-810 (1990).
28. Kei Nakajima, Toshitaka Muneyuki, Hiromi Munakat and Masafumi Kakei, Revisiting the cardiometabolic relevance of serum amylase. BMC Res Notes 4:419-426 (2011).
29. Ali H, Houghton PJ and Soumyanath A, Alpha-amylase inhibitory activity of some Malaysian plants used to treat diabetes; with particular reference to Phyllanthus amarus. J Ethnopharmacol 107:449-455 (2006).
30. Garg A, Adipose tissue dysfunction in obesity and lipodystrophy. Clin Cornerstone 8:S7-S13 (2006).
31. Staiger H and Haring HU, Adipocytokines: fat-derived humoral mediators of metabolic homeostasis. Exp Clin Endocrinol Diabetes 113:37-79 (2005).
32. Weigle DS, Cummings DE, Newby PD, Breen PA, Frayo RS, Matthys CC, et al, Roles of leptin and ghrelin in the loss of body weight caused by a lowfat, high carbohydrate diet. J Clin Endocrinol Metabol 88:1577-1586 (2003).
33. Handjieva-Darlenska T and Boyadjieva N, The effect of high-fat diet on plasma ghrelin and leptin levels in rats. J Physiol Biochem 65:157-164 (2009).
34. Dubuc GR, Phinney SD, Stern JS and Havel PJ, Changes of serum leptin and endocrine and metabolic parameters after 7 days of energy restriction in men and women. Metabolism 47:429-434 (1998).